Onpattro Now Approved: Patient and HCP-facing pages

Aug 30, 2018Aug 27, 2018

Brand: Onpattro (patisiran), Injection
Parent Company: Alnylam
Drug Type: Prescription
Drug Category: Immunology
Campaign: now-approved
Targeting: HCPs, Patients, Caregivers
Patient Website: https://www.onpattro.com/
HCP Website: https://www.onpattro.com/hcp/

: Homepage (Patients)

: Alnylam Assist

: Sign Up (Patient form)

: Homepage (HCP)

: Homepage (Mobile, Patient)

: HCP Mobile Nav